Astex scientists describe novel HSP90 inhibitors in two key publications in Journal of Medicinal Chemistry -- more

GE Capital Provides $5 Million Credit Facility To Mitralign, Inc. -- more

VaxInnate: Two Start-Ups Aim To Change Economics Of Vaccine Production -- more

Fairfield County resident, Cornelius T. Ryan, named one of the “Irish Life Science 50” -- more

MorphoSys and Xencor Sign License and Collaboration Agreement for Clinical Antibody Program -- more

Gilead Sciences to Acquire CGI Pharmaceuticals for Up to $120 Million -- more

Santhera's Catena® Improved Vision in Patients with Leber's Hereditary Optic Neuropathy; Regulatory Submissions Planned in First Half of 2011 -- more

AVEO Pharmaceuticals Granted Patents for Diagnostic Tests to Identify Patient Populations Likely to Respond to Tivozanib Treatment -- more

ExonHit signs an exclusive agreement with Genmab for novel splice variant targets in breast cancer -- more

BRAINCELLS INC. Announces Results from Exploratory Phase 2A Trial of BCI-540 in Depression with Anxiety -- more

Asterand Signs Agreement with Amylin Pharmaceuticals -- more

ExonHit discloses the final terms of the acquisition of RedPath Integrated Pathology -- more

EPA Extends Asterand’s Role in ToxCast ™ Program -- more

AVEO Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating SCH 900105 (AV-299) in Non-Small Cell Lung Cancer -- more

Novozymes and Ceres partner on biofuel crops -- more

Scientists Weigh Use of Bacteria for Cleaner Fossil Fuel Production -- more